Évaluation de l'efficacité et de la tolérance du traitement antirétroviral chez des patients infectés par le VIH-2 à Dakar : étude préliminaire
- 28 February 2006
- journal article
- abstracts
- Published by Elsevier BV in Medecine Et Maladies Infectieuses
- Vol. 36 (2), 111-114
- https://doi.org/10.1016/j.medmal.2005.11.012
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patientsAIDS, 2003
- Antiretroviral therapy in HIV-2-infected patientsAIDS, 2003
- The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up studyAIDS, 2002
- Antiretroviral Therapy for HIV-2 Infected PatientsJournal of Infection, 2001
- Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infectionAIDS, 2000
- Amprenavir: A new human immunodeficiency virus type 1 protease inhibitorClinical Therapeutics, 2000
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1Science, 1994
- Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitorsFEBS Letters, 1994
- Cellular and plasma viral load in patients infected with HIV-2AIDS, 1993